Public-registry site landscape for NCT07741877, a Sarcoma study sponsored by Iovance Biotherapeutics, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07741877 (registry record) |
| Sponsor | Iovance Biotherapeutics, Inc. |
| Condition(s) | Sarcoma; Soft Tissue Sarcoma (STS); Advanced Soft Tissue Sarcoma; Undifferentiated Pleomorphic Sarcoma (UPS) |
| Phase | PHASE2 |
| Listed sites | 0 |
Eichor generates a preliminary site-risk snapshot for NCT07741877 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →